From: Implementation of individualised polygenic risk score analysis: a test case of a family of four
Phenotype | PT00007A (Father) | PT00008A (Mother) | PT00009A (Daughter) | PT00002A (Son) |
---|---|---|---|---|
Colorectal Cancer | 97.42 | 79.92 | 97.22 | 91.05 |
Coronary artery disease | 29.62 | 96.62 | 89.86 | 81.91 |
Testicular cancer | 42.35 | 90.66 | 95.83 | 38.37 |
Glaucoma | 88.67 | 42.35 | 65.01 | 65.21 |
Type 2 diabetes | 60.44 | 71.37 | 68.79 | 45.33 |
Prostate cancer | 50.50 | 80.91 | 92.45 | 21.67 |
Thyroid cancer | 49.30 | 50.50 | 32.41 | 90.66 |
Breast cancer | 17.30 | 85.69 | 53.28 | 64.61 |
Ischaemic stroke | 26.24 | 82.90 | 64.02 | 38.17 |
Inflammatory bowel disease | 43.54 | 70.78 | 46.72 | 46.72 |
Chronic lymph leukaemia | 16.50 | 45.53 | 41.15 | 44.14 |
Basal cell carcinoma | 55.86 | 7.55 | 10.54 | 14.12 |
Glioma | 4.57 | 42.35 | 18.69 | 5.96 |
Melanoma | 14.51 | 9.74 | 22.86 | 23.26 |
Atrial fibrillation | 16.50 | 15.51 | 8.55 | 7.16 |